Item 2.02 Results of Operations and Financial Condition.

On November 4, 2009, Dialysis Corporation of America issued a press release announcing its financial results for the third quarter ended September 30, 2009. A copy of the November 4, 2009 press release is attached as an exhibit to this Current Report and is incorporated herein by reference.

The information furnished pursuant to Item 2.02, including the Exhibit
(99)(i), shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933.

Dialysis Corporation of America will be hosting a conference call in conjunction with the press release of its financial results attached as the exhibit to this current report. The conference call will be held on Thursday, November 5, 2009 at 10:00 a.m. EST. The call is accessible either by dialing 1-866-814-8476 (and providing attendee code 1405582), or by simulcast on the internet at http://www.startconference.com using Conference ID number 2135668. Participants may be asked to provide the title of the conference call, which is "Dialysis Corporation of America Third Quarter Earnings." A copy of this current report on Form 8-K and the attached press release announcing the financial results for the third quarter ended September 30, 2009 will be available through the company's website, www.dialysiscorporation.com, under the "Investor Relations - SEC Filings" tabs. A replay of the conference call will be available on the company's website for a period of thirty days following the conference call.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits

(99) Additional exhibits

(i) Press Release dated November 4, 2009.